BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 27038446)

  • 21. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
    Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
    Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
    De Backer AI; De Schepper AM; Pelckmans P
    Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
    Gorrepati VS; Sharma P
    Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
    Padmavathy F; Siddaraju N; Sistla SC
    Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the endoscopic surveillance of Barrett's oesophagus.
    Bergman JJ; Tytgat GN
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Barrett's esophagus].
    Neuhaus H
    Praxis (Bern 1994); 2004 Nov; 93(47):1951-7. PubMed ID: 15656005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for Barrett's esophagus.
    Zakko L; Lutzke L; Wang KK
    Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Barrett's neoplasia: where is the problem?].
    Krugmann J; Vieth M; Neumann H
    Zentralbl Chir; 2014 Aug; 139(4):386-92. PubMed ID: 25119577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus.
    Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A
    Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
    Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
    Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma.
    Ormeci N; Savas B; Coban S; Palabiyikoğlu M; Ensari A; Kuzu I; Kursun N
    Surg Endosc; 2008 Mar; 22(3):693-700. PubMed ID: 17704887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia.
    Takubo K; Vieth M; Aida J; Sawabe M; Kumagai Y; Hoshihara Y; Arai T
    Digestion; 2009; 80(4):248-57. PubMed ID: 19828957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic therapy of esophageal premalignancy and early malignancy.
    Nealis TB; Washington K; Keswani RN
    J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflux disease and Barrett's esophagus.
    Koop H
    Endoscopy; 2000 Feb; 32(2):101-7. PubMed ID: 10696837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.